---
title: Accelevir vs NorthEast BioLab
slug_a: accelevirdx
slug_b: nebiolab
site: cro
review_signal_gate: closed
canonical_path: /compare/accelevirdx/nebiolab
---

# Accelevir vs NorthEast BioLab

Side-by-side profile data from each company listing on this directory.

## Accelevir

- Profile: [/companies/accelevirdx](/companies/accelevirdx)

Accelevir — CLIA-certified CRO specializing in ultra-sensitive molecular analytics, custom immunology assays, and integrated virology-immunology workflows for cell therapies, gene editing, and infectious disease programs.

Services: 8. Modalities: 3. Indications: 3. Locations: 1. Certifications: 1. The strongest documented coverage currently appears in services (8).

### Services

- Biomarker Assays
- Flow Cytometry Services
- Clinical Trial Services
- Central Laboratory Services
- Translational Research
- Virology Services
- Immunology & Inflammation Services
- Genomics & Sequencing Services

### Modalities

- Cell Therapy
- Gene Therapy
- Vaccine

### Indications

- Oncology
- Immunology
- Infectious Disease

### Phases

- Preclinical (General)
- Phase I
- Phase II
- Phase III

### Sourcing models

- Full-Service Outsourcing (FSO)

## NorthEast BioLab

- Profile: [/companies/nebiolab](/companies/nebiolab)

NorthEast BioLab — Bioanalytical CRO providing PK/PD, immunogenicity (ADA/nAb), cytokine, and biomarker assays across LC-MS, Meso Scale Discovery, ELISA, and ddPCR platforms. Operates GLP/GCLP-compliant facilities and reports DEA and CT approval for Schedule I–IV bioanalysis.

Services: 13. Modalities: 6. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (13).

### Services

- In Vitro ADME / DMPK
- Preclinical In Vivo Studies
- In Vivo PK / PD Studies
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- Clinical Trial Services
- Central Laboratory Services
- Analytical Method Development & Validation
- ICH Stability Studies

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Data not yet provided.